|Lancet Oncology||Tuesday, August 30, 2016||
Background: Cancer of unknown primary ranks in the top ten cancer presentations and has an extremely poor prognosis. Identification of the primary tumour and development of a tailored site-...
|Cancer Discovery||Monday, June 20, 2016||
A patient with metastatic BRAF-mutated colorectal cancer initially responded to combined EGFR and BRAF inhibition with panitumumab plus vemurafenib. Pre-existing cells with increased MET gene copy...
|Sci Transl Med||Monday, February 29, 2016||
|Nature||Wednesday, September 30, 2015||
Nature. 2015 Sep 30. doi: 10.1038/nature14969. [Epub ahead of print]
|Cancer Res.||Friday, July 3, 2015||
Cancer Res. 2015 Jul 3. pii: canres.0356.2015. [Epub ahead of print]
|J Mol Med (Berl).||Friday, July 3, 2015||
J Mol Med (Berl). 2015 Jul 3. [Epub ahead of print]
|Ann Oncol.||Thursday, June 25, 2015||
Ann Oncol. 2015 Jun 25. pii: mdv272. [Epub ahead of print]
|Clin Cancer Res.||Friday, June 12, 2015||
Clin Cancer Res. 2015 Jun 12. pii: clincanres.0848.2015. [Epub ahead of print]
|Mol Oncol.||Friday, June 5, 2015||
Vigna E, Chiriaco C, Cignetto S, Fontani L, Basilico C, Petronzelli F, Comoglio PM.
|Nat Med.||Monday, June 1, 2015||
Nat Med. 2015 Jun 1. doi: 10.1038/nm.3870. [Epub ahead of print]